Development and administration of live Shigella vaccines.
D000818:Animals; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000145:classification / Q000276:immunology*; D002642:Chick Embryo; D004341:Drug Evaluation / Q000379:methods; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004405:Dysentery, Bacillary / Q000517:prevention & control; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007111:Immunity, Cellular; D051379:Mice; D009154:Mutation; D010587:Phagocytosis; D012760:Shigella / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D014774:Virulence
D001428:Bacterial Vaccines